Current Diabetes Reports

, Volume 7, Issue 2, pp 114–122

Recent advances in understanding depression in adults with diabetes

  • Patrick J. Lustman
  • Sue M. Penckofer
  • Ray E. Clouse
Article

Abstract

The authors review the science linking depression with diabetes. Some recent heuristic research is identified that highlights progress in the field and is directing future research. Issues in the management of depression in diabetes are outlined, including interactions of depression and insulin resistance.

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References and Recommended Reading

  1. 1.
    Relman AS, Angell M: Resolved: psychosocial interventions can improve clinical outcomes in organic disease (con). Psychosom Med 2002, 64:558–563.PubMedCrossRefGoogle Scholar
  2. 2.
    Willis T, ed: Diabetes: A Medical Odyssey. New York: Tuckahoe; 1971.Google Scholar
  3. 3.
    Winokur A, Maislin G, Phillips JL, Amsterdam JD: Insulin resistance after oral glucose tolerance testing in patients with major depression. Am J Psychiatry 1988, 145:325–330.PubMedGoogle Scholar
  4. 4.
    Turkington RW: Depression masquerading as diabetic neuropathy. JAMA 1980, 243:1147–1150.PubMedCrossRefGoogle Scholar
  5. 5.
    Feighner JP, Robins E, Guze SB, et al.: Diagnostic criteria for use in psychiatric research. Arch Gen Psychiatry 1972, 26:57–63.PubMedGoogle Scholar
  6. 6.
    Eaton WW, Armenian HA, Gallo J, et al.: Depression and risk for onset of type II diabetes: a prospective population-based study. Diabetes Care 1996, 19:1097–1102.PubMedCrossRefGoogle Scholar
  7. 7.
    Lustman PJ, Griffith LS, Gavard JA, Clouse RE: Depression in adults with diabetes. Diabetes Care 1992, 15:1631–1639.PubMedCrossRefGoogle Scholar
  8. 8.
    Lustman PJ, Clouse RE: Treatment of depression in diabetes: impact on mood and medical outcome. J Psychosom Res 2002, 53:917–924.PubMedCrossRefGoogle Scholar
  9. 9.
    Knol MJ, Twisk JW, Beekman AT, et al.: Depression as a risk factor for the onset of type 2 diabetes mellitus. A meta-analysis. Diabetologia 2006, 49:837–845.PubMedCrossRefGoogle Scholar
  10. 10.
    Clouse RE, Lustman PJ, Freedland KE, et al.: Depression and coronary heart disease in women with diabetes. Psychosom Med 2003, 65:376–383.PubMedCrossRefGoogle Scholar
  11. 11.
    Saydah SH, Eberhardt MS, Loria CM, Brancati FL: Age and the burden of death attributable to diabetes in the United States. Am J Epidemiol 2002, 156:714–719.PubMedCrossRefGoogle Scholar
  12. 12.
    Glass GV: Primary, secondary, and meta-analysis of research. Educ Researcher 1976, 5:3–8.CrossRefGoogle Scholar
  13. 13.
    Rosenthal R, ed: Meta-analytic Procedures for Social Research. Beverly Hills, CA: Sage Press; 1984.Google Scholar
  14. 14.
    Hunter JE, Schmidt FL, Jackson GB, eds: Meta-analysis: Cumulating Research Findings Across Studies. Beverly Hills, CA: Sage Press, 1982.Google Scholar
  15. 15.
    Anderson RJ, Freedland KE, Clouse RE, Lustman PJ: The prevalence of comorbid depression in adults with diabetes: a meta-analysis. Diabetes Care 2001, 24:1069–1078.PubMedCrossRefGoogle Scholar
  16. 16.
    Lustman PJ, Anderson RJ, Freedland KE, et al.: Depression and poor glycemic control: a meta-analytic review of the literature. Diabetes Care 2000, 23:434–442.CrossRefGoogle Scholar
  17. 17.
    de Groot M, Anderson RJ, Freedland KE, et al.: Association of depression and diabetes complications: a meta-analysis. Psychosom Med 2001, 63:619–630.PubMedGoogle Scholar
  18. 18.
    Lustman PJ, Griffith LS, Clouse RE, et al.: Effects of nortriptyline on depression and glycemic control in diabetes: results of a double-blind, placebo-controlled trial. Psychosom Med 1997, 59:241–250.PubMedGoogle Scholar
  19. 19.
    Lustman PJ, Clouse RE, Nix BD, et al.: Sertraline for prevention of depression recurrence in diabetes mellitus: a randomized, double-blind, placebo-controlled trial. Arch Gen Psychiatry 2006, 63:521–529.PubMedCrossRefGoogle Scholar
  20. 20.
    Williams MM, Clouse RE, Nix BD, et al.: Efficacy of sertraline in prevention of depression recurrence in older versus younger adults with diabetes. Diabetes Care 2007, in press.Google Scholar
  21. 21.
    Lustman PJ, Clouse RE, Sayuk GS, et al.: Factors influencing glycemic control in type 2 diabetes during acute-and maintenance-phase treatment of major depressive disorder with bupropion. Diabetes Care 2007, in press.Google Scholar
  22. 22.
    Steinbrook R: Facing the diabetes epidemic—mandatory reporting of glycosylated hemoglobin values in New York City. N Engl J Med 2006, 354:545–548.PubMedCrossRefGoogle Scholar
  23. 23.
    Narayan KM, Boyle JP, Thompson TJ, et al.: Lifetime risk for diabetes mellitus in the United States. JAMA 2003, 290:1884–1890.PubMedCrossRefGoogle Scholar
  24. 24.
    American Diabetes Association: Standards of medical care in diabetes—2007. Diabetes Care 2007 30(suppl 1):S4–S41.CrossRefGoogle Scholar
  25. 25.
    Kawakami N, Takatsuka N, Shimizu H, Ishibashi H: Depressive symptoms and occurrence of type 2 diabetes among Japanese men. Diabetes Care 1999, 22:1071–1076.PubMedCrossRefGoogle Scholar
  26. 26.
    Everson-Rose SA, Meyer PM, Powell LH, et al.: Depressive symptoms, insulin resistance, and risk of diabetes in women at midlife. Diabetes Care 2004, 27:2856–2862.PubMedCrossRefGoogle Scholar
  27. 27.
    Arroyo C, Hu FB, Ryan LM, et al.: Depressive symptoms and risk of type 2 diabetes in women. Diabetes Care 2004, 27:129–133.PubMedCrossRefGoogle Scholar
  28. 28.
    Stewart AL, Hays RD, Ware JE Jr: The MOS short-form general health survey: reliability and validity in a patient population. Med Care 1988, 26:724–735.PubMedCrossRefGoogle Scholar
  29. 29.
    Golden SH, Williams JE, Ford DE, et al.: Depressive symptoms and the risk of type 2 diabetes: the Atherosclerosis Risk in Communities study. Diabetes Care 2004, 27:429–435.PubMedCrossRefGoogle Scholar
  30. 30.
    Carnethon MR, Kinder LS, Fair JM, et al.: Symptoms of depression as a risk factor for incident diabetes: findings from the National Health and Nutrition Examination Epidemiologic Follow-up Study, 1971–1992. Amer J Epidemiol 2003, 158:416–423.CrossRefGoogle Scholar
  31. 31.
    Symons MJ, Moore DT: Hazard rate ratio and prospective epidemiological studies. J Clin Epidemiol 2002, 55:893–899.PubMedCrossRefGoogle Scholar
  32. 32.
    Walter SD: Choice of effect measure for epidemiological data. J Clin Epidemiol 2000, 53:931–939.PubMedCrossRefGoogle Scholar
  33. 33.
    DerSimonian R, Laird N: Meta-analysis in clinical trials. Control Clin Trials 1986, 7:177–188.PubMedCrossRefGoogle Scholar
  34. 34.
    van den Akker, Schuurman A, Metsemakers J, Buntinx F: Is depression related to subsequent diabetes mellitus? Acta Psychiatr Scand 2004, 110:178–183.PubMedCrossRefGoogle Scholar
  35. 35.
    Palinkas LA, Lee PP, Barrett-Connor E: A prospective study of type 2 diabetes and depressive symptoms in the elderly: the Rancho Bernardo Study. Diabet Med 2004, 21:1185–1191.PubMedCrossRefGoogle Scholar
  36. 36.
    Kumari M, Head J, Marmot M: Prospective study of social and other risk factors for incidence of type 2 diabetes in the Whitehall II study. Arch Intern Med 2004, 164:1873–1880.PubMedCrossRefGoogle Scholar
  37. 37.
    Lustman PJ, Clouse RE: Depression in diabetic patients: the relationship between mood and glycemic control. J Diabetes Complications 2005, 19:113–122.PubMedGoogle Scholar
  38. 38.
    Selvin E, Marinopoulos S, Berkenblit G, et al.: Meta-analysis: glycosylated hemoglobin and cardiovascular disease in diabetes mellitus. Ann Intern Med 2004, 141:421–431.PubMedGoogle Scholar
  39. 39.
    Egede LE, Nietert PJ, Zheng D: Depression and all-cause and coronary heart disease mortality among adults with and without diabetes. Diabetes Care 2005, 28:1339–1345.PubMedCrossRefGoogle Scholar
  40. 40.
    Zhang X, Norris SL, Gregg EW, et al.: Depressive symptoms and mortality among persons with and without diabetes. Am J Epidemiol 2005, 161:652–660.PubMedCrossRefGoogle Scholar
  41. 41.
    Katon WJ, Rutter C, Simon G, et al.: The association of comorbid depression with mortality in patients with type 2 diabetes. Diabetes Care 2005, 28:2668–2672.PubMedCrossRefGoogle Scholar
  42. 42.
    National Institutes of Health: Fact Sheet: Type 2 Diabetes. Available at http://www.nih.gov/about/researchresultsforthepublic/Type2Diabetes.pdf. Accessed January 12, 2007.
  43. 43.
    Lustman PJ, Freedland KE, Griffith LS, Clouse RE: Fluoxetine for depression in diabetes: a randomized, double-blind, placebo-controlled trial. Diabetes Care 2000, 23:618–623.PubMedCrossRefGoogle Scholar
  44. 44.
    Lustman PJ, Griffith LS, Freedland KE, et al.: Cognitive behavior therapy for depression in type 2 diabetes: a randomized controlled trial. Ann Intern Med 1998, 129:613–621.PubMedGoogle Scholar
  45. 45.
    Okamura F, Tashiro A, Utumi A, et al.: Insulin resistance in patients with depression and its changes during the clinical course of depression: minimal model analysis. Metab Clin Exp 2000, 49:1255–1260.PubMedGoogle Scholar
  46. 46.
    Lustman PJ, Griffith LS, Clouse RE: Depression in adults with diabetes: results of a 5-year follow-up study. Diabetes Care 1988, 11:605–612.PubMedCrossRefGoogle Scholar
  47. 47.
    Lustman PJ, Griffith LS, Freedland KE, Clouse RE: The course of major depression in diabetes. Gen Hosp Psychiatry 1997, 19:138–143.PubMedCrossRefGoogle Scholar
  48. 48.
    Katon WJ, Von Korff M, Lin EH, et al.: The Pathways Study: a randomized trial of collaborative care in patients with diabetes and depression. Arch Gen Psychiatry 2004, 61:1042–1049.PubMedCrossRefGoogle Scholar

Copyright information

© Current Medicine Group LLC 2007

Authors and Affiliations

  • Patrick J. Lustman
    • 1
  • Sue M. Penckofer
  • Ray E. Clouse
  1. 1.Department of PsychiatryWashington University School of MedicineSt. LouisUSA

Personalised recommendations